🇫🇷
France · FR · FR:62183964
IRBESARTAN HYDROCHLOROTHIAZIDE TEVA 300 mg/12,5 mg, comprimé pelliculé
ReimbursedATC C09CA04
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerTEVA (PAYS-BAS)
CountryFR (France)
ATC codeC09CA04
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 2
- cip133400922168562plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)EUR 3.64
- cip133400922168852plaquette(s) thermoformée(s) PVC PVDC aluminium de 90 comprimé(s)EUR 10.53
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "62183964",
"date_amm": "2009-11-26",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/09/583",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code C09CA04.
Access this data programmatically
Query IRBESARTAN HYDROCHLOROTHIAZIDE TEVA 300 mg/12,5 mg, comprimé pelliculé and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.